Shanghai, China, 15 January, 2021 —The U-track Intracranial Support Catheter System, a product developed by Shanghai MicroPort® NeuroTech Co., Ltd. (MicroPort® NeuroTech) for establishing vascular access in neurointerventional procedures, recently received a registration certificate issued by the Chinese National Medical Products Administration (NMPA).
The approval of the U-track Intracranial Support Catheter System marks the further development of the neurointerventional portfolio of MicroPort® NeuroTech. “Modern neurointerventional therapy requires increasingly high quality vascular access. The approval of MicroPort® NeuroTech’s high performance U-track Intracranial Support Catheter System will provide strong support for neurointerventional procedures, taking us one step closer to our goal of becoming a ‘comprehensive stroke treatment solution provider’,” said Zhiyong Xie, President of MicroPort® NeuroTech.
Compared with rival products, MicroPort® NeuroTech’s U-track Intracranial Support Catheter System features a larger lumen, easing the delivery of multiple devices, and a rounded tip design for safe tracking through the tortuous vessels to reach the desired neurovascular locations during clinical procedures, while ensuring outstanding support, pushability and buckling resistance.
The endovascular approach has gradually become a mainstream method for treating intracranial lesions. Different interventional procedures demand higher performance from guiding catheters, which ideally must establish a stable pathway for the procedure, as well as provide a strong support for medical device delivery. However, conventional guiding catheters generally do not reach beyond the internal carotid artery or the extracranial segment of the vertebral artery, preventing the crossing of tortuous vessels. In order to meet the increasingly high clinical demand in terms of accessing tortuous distal anatomies, while avoiding complications, it is often necessary to use guiding catheters in conjunction with support catheters when dealing with tortuous distal vascular access.